Great clinical care begins with the first step: diagnosis
However easy access to diagnostics is far from guaranteed, 47 % of the global population still doesn’t have access to basic diagnostics for many common diseases. This deficiency results in delayed treatments, increased mortality rates and a higher burden on healthcare systems.
We develop fast, simple, precise and low cost on-site testing solutions, from end to end, that embrace:
Molecular
Biology
Molecular Biology
Protein
Engineering
Protein Engineering
1) Using large protein and enzyme databases, we train Artificial Intelligence models to infer the principles governing protein structure and function, and generate valuable new patterns from there on.
2) We use deep learning models to predict the 3D structure of the protein, providing information about its potential usability and viability.
3) We select our protein candidates, which are expressed and functionally validated in vitro in our laboratories.
Microengineering
Microengineering
All of them boosted by Artificial Intelligence.
SMART® Combines the specificity and sensitivity of CRISPR and isothermal amplification in portable on-site devices developed by us.
Simple
Automated processes that can be followed by anyone. From sample to results.
Molecular
Tailored solutions to identify any DNA, RNA or protein target and detect.
Accesible
Convenient and low cost solutions ready to be used at the point-of-need.
Rapid Test
High quality life saving results in a fraction of the time.
User friendly solutions with immediate impact:
Saving lives made simple
Sample
Collection
The device is suitable for multiple types of samples.
Amplification
Reaction
Results within 60 minutes
Qualitative and quantitative results simplify test interpretation.
Smart
Data
Fast and precise results to make better decisions on a daily and long-term basis.
Sample
Collection
The device is suitable for multiple types of samples.
Amplification
Enrichment of the target of interest by placing the sample in the SMART® device.
Reaction
Detection of the target of interest from CRISPR-Cas nucleases.
Results within 60 minutes
Qualitative and quantitative results simplify test interpretation.
Smart
Data
Fast and precise results to make better decisions on a daily and long-term basis.
The evolution of today's technologies
PCR/qPCR
- HIGHER ACCURACY
- DIRECT NUCLEIC ACID ANALYSIS
- CAPEX $ $ $ $
- SPEED 12 h
- PORTABILITY
- SIMPLICITY OF USE
Fluorescent NASBA
- HIGHER ACCURACY
- DIRECT NUCLEIC ACID ANALYSIS
- CAPEX $ $ $ $
- SPEED 3 h
- PORTABILITY
- SIMPLICITY OF USE
Microbiological Culture
- CAPEX $
- SPEED 24 - 72 h
- SIMPLICITY OF USE
- HIGHER ACCURACY
- DIRECT NUCLEIC ACID ANALYSIS
- PORTABILITY
Limay
- HIGHER ACCURACY
- DIRECT NUCLEIC ACID ANALYSIS
- PORTABILITY
- CAPEX $
- SPEED 60 min.
- SIMPLICITY OF USE
PCR/qPCR | Fluorescent NASBA | Microbiological Culture | Limay | |
---|---|---|---|---|
Higher accuracy | ||||
Direct nucleic acid analysis | ||||
Portability | ||||
Capex | $ $ $ $ | $ $ $ $ | $ | $ |
Speed | 12 h | 3 h | 24 72 h | 60 mins |
Simplicity of uses |
Innovation is in our DNA, so development is continuous and the future impact is massive.
We are tirelessly dedicated to the continuous research and development of advanced technologies.
This allows us to constantly innovate in simplifying and accelerating the testing process.
We are forging a better future in our state of the art facilities
Our 200 square meter laboratory in Buenos Aires biotechnological hub is equipped with advanced technology. This space is organized in specialized independent areas with proper layout to make them suitable for our research in molecular biology, protein engineering and microfluidics.
Additionally, we have a microengineering area and a section for designing, prototyping, developing, and 3D printing our portable devices.
Innovation with impact
Good health and well-being
We improve the access and quality of molecular diagnostics, enabling rapid results to make the best decisions in real time.
Reduced inequalities
We contribute to creating access to diagnostics for low-income regions, closing the gap in access to health services and improving equity in medical care.
Industry, innovation and infrastructure
We generate scientific innovation and new industries by increasing access to information and communication technologies. We provide diagnostic infrastructure to underdeveloped countries.
Partnerships for the goals
We promote collaboration and information exchange. By being able to share real-time health results, we contribute to the joint prevention of future pandemics and epidemics.
Limay's team is a blend of experienced scientists and entrepreneurs.
Our team is truly multidisciplinary.
Biologists, engineers, designers, medical researchers, entrepreneurs… and a lot more to come!
Our accomplishments validate our work
Santander X Argentina Award
STARTUPS 2023
AceleraBA
Startup Chile
Fondo Tecnológico Argentino
Grant received
Emprendimientos Dinámicos
Grant received
Fondo Argentino Sectorial
Grant received
Get in touch!
Join the revolution
and let’s change the world!
Contact us
Maipú 942 (C1006ACN)
Buenos Aires, Argentina.